The Massachusetts Health Policy Commission identifies significant competitive overlap in a proposed merger of several hospital systems as it would enhance the bargaining leverage with insurers (Beth Israel Lahey Health / Partners HealthCare)

This article has been nominated for the 2020 Antitrust Writing Awards. Click here to learn more about the Antitrust Writing Awards.

A STRONGER SECOND COMPETITOR? ANALYZING THE COMPETITIVE EFFECTS OF THE BETH ISRAEL LAHEY HEALTH TRANSACTION* I. BACKGROUND Could a merger between rival firms create a stronger second competitor to the market leader in a way that strengthens competition and benefits consumers? The answer is theoretically ambiguous, and little if any empirical economic research squarely addresses this question. Recently, however, the Massachusetts Health Policy Commission (“HPC”) analyzed this very issue in its evaluation of a proposed merger of several hospital systems in the Boston area. Specifically, the HPC evaluated whether the new system, Beth Israel Lahey Health (“BILH”), would be able to compete more effectively with Partners HealthCare (“Partners”), the largest and most expensive healthcare system

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Authors

Quotation

Zenon Zabinski, Tetyana Shvydko, Kayuna Fukushima, Dr. Cory S. Capps, The Massachusetts Health Policy Commission identifies significant competitive overlap in a proposed merger of several hospital systems as it would enhance the bargaining leverage with insurers (Beth Israel Lahey Health / Partners HealthCare), 27 September 2018, e-Competitions September 2018, Art. N° 96866

Visites 24

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues